The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation

Willem Fibbe; Rosa Bernardi; Pierre Charbord; Daniela Krause; Cristina Lo Celso; Simón Méndez-Ferrer; Christine Mummery; Robert Oostendorp; Marc Raaijmakers; Gerard Socié; Frank Staal; Andrea Bacigalupo

doi:10.1097/HS9.0000000000000714

The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation

Willem Fibbe^*, Rosa Bernardi, Pierre Charbord, Daniela Krause, Cristina Lo Celso, Simón Méndez-Ferrer, Christine Mummery, Robert Oostendorp, Marc Raaijmakers, Gerard Socié, Frank Staal, Andrea Bacigalupo

^*Corresponding author for this work

Hematology

Research output: Contribution to journal › Review article › Academic › peer-review

1 Citation (Scopus)

14 Downloads (Pure)

Original language	English
Pages (from-to)	E0714
Journal	HemaSphere
Volume	6
Issue number	5
DOIs	https://doi.org/10.1097/HS9.0000000000000714
Publication status	Published - May 2022

Bibliographical note

Funding Information:
WF is a chairman DSMB in the Glycostem Therapeutics and advisor for Starfish Innovations. DK receives research funding from Merck. CM received research funding from Sartorius. AB receives speaker’s fees from SANOFI, MSD, Therakos, Novartis, JAZZ, ADIENNE. All the other authors have no conflicts of interest to disclose.

Access to Document

10.1097/HS9.0000000000000714Licence: CC BY

The_EHA_Research_Roadmap__Hematopoietic_Stem_Cells.7Final published version, 423 KBLicence: CC BY

Cite this

@article{3943be2bb38541e0af59f83185b75918,

title = "The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation",

author = "Willem Fibbe and Rosa Bernardi and Pierre Charbord and Daniela Krause and {Lo Celso}, Cristina and Sim{\'o}n M{\'e}ndez-Ferrer and Christine Mummery and Robert Oostendorp and Marc Raaijmakers and Gerard Soci{\'e} and Frank Staal and Andrea Bacigalupo",

note = "Funding Information: WF is a chairman DSMB in the Glycostem Therapeutics and advisor for Starfish Innovations. DK receives research funding from Merck. CM received research funding from Sartorius. AB receives speaker{\textquoteright}s fees from SANOFI, MSD, Therakos, Novartis, JAZZ, ADIENNE. All the other authors have no conflicts of interest to disclose.",

year = "2022",

month = may,

doi = "10.1097/HS9.0000000000000714",

language = "English",

volume = "6",

pages = "E0714",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "5",

}

TY - JOUR

T1 - The EHA Research Roadmap

T2 - Hematopoietic Stem Cells and Allotransplantation

AU - Fibbe, Willem

AU - Bernardi, Rosa

AU - Charbord, Pierre

AU - Krause, Daniela

AU - Lo Celso, Cristina

AU - Méndez-Ferrer, Simón

AU - Mummery, Christine

AU - Oostendorp, Robert

AU - Raaijmakers, Marc

AU - Socié, Gerard

AU - Staal, Frank

AU - Bacigalupo, Andrea

N1 - Funding Information: WF is a chairman DSMB in the Glycostem Therapeutics and advisor for Starfish Innovations. DK receives research funding from Merck. CM received research funding from Sartorius. AB receives speaker’s fees from SANOFI, MSD, Therakos, Novartis, JAZZ, ADIENNE. All the other authors have no conflicts of interest to disclose.

PY - 2022/5

Y1 - 2022/5

UR - http://www.scopus.com/inward/record.url?scp=85131678555&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000714

DO - 10.1097/HS9.0000000000000714

M3 - Review article

AN - SCOPUS:85131678555

SN - 2572-9241

VL - 6

SP - E0714

JO - HemaSphere

JF - HemaSphere

IS - 5

ER -

The EHA Research Roadmap: Hematopoietic Stem Cells and Allotransplantation

Bibliographical note

Access to Document

Other files and links

Cite this